Sector Performance: The overall health and investor sentiment towards the pharmaceutical industry in South Korea greatly influences stock prices.

Company Financials: Revenue, profit margins, debt levels, and growth prospects directly impact investor confidence and valuation.

Regulatory Changes: Government policies and regulations regarding drug pricing, approvals, and healthcare significantly affect profitability.

Competition: Actions of competitors, including new drug launches and market share battles, can influence the stock's demand and price.

Economic Conditions: Interest rates, inflation, and economic growth in South Korea impact investment decisions and overall market sentiment.

Global Events: International events, such as pandemics or geopolitical tensions, can affect supply chains and investor risk appetite.

Investor Sentiment: Positive or negative news articles, analyst ratings, and general market trends can drive short-term price fluctuations.

Drug Development: Clinical trial results, drug approvals, and pipeline progress significantly impact perceived future value and investor enthusiasm.